Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose

登录注册会员服务联系我们

Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose–Response Study

Published:2007-07 Issue:1 Volume:52 Page:106-115
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fradet Yves,Egerdie Blair,Andersen Morten,Tammela Teuvo L.J.,Nachabe Mahmoud,Armstrong Jon,Morris Thomas,Navani Sunil

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. Tolerability of antiandrogens in the treatment of prostate cancer;Fourcade;Urooncology,2004

2. Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy;Migliari;Arch Ital Urol Androl,1999

3. The role of antiandrogen monotherapy in the treatment of prostate cancer;Anderson;BJU Int,2003

4. Antiandrogens in the treatment of prostate cancer;Wirth;Eur Urol,2007

5. Gynaecomastia: aetiology and treatment options;Tyrrell;Prostate Cancer Prostatic Dis,1999

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to the patient with Gynecomastia: Beyond the basics;Amrita Journal of Medicine;2024-04

2. Gynecomastia;Testosterone;2023

3. Gynécomastie en pratique clinique pour les urologues;Urologie in der Praxis;2021-10-20

4. Summary, discussion, and conclusions;Prostate Cancer Metabolism;2021

5. Indications and Complications of Androgen Deprivation Therapy;Seminars in Oncology Nursing;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP